Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
Pharma Industry Sandwiched by the "Toughest" Drug Regulation and Cost ...
Chief Editor James Shen offers his regular monthly review of the Chinese healthcare sector with this month's emphasis on the toughening drug regulatory regime, new tender... (6/29/2015)
   
SciClone Pharmaceuticals: Building a Product Portfolio Optimized for China's Evolving Pharmaceutical Market (7/2/2015)
The Impact of Restricted Data-flows on China's Digital Healthcare Solutions (7/1/2015)
Rejection of Gilead Patent Raises Issues for Companies Seeking Pharmaceutical Patent Protection in China (6/30/2015)
Pharma Industry Sandwiched by the "Toughest" Drug Regulation and Cost Containment (6/29/2015)
Fosun Pharma Aims to Expand Global Business Via M&As and Innovative R&D (6/24/2015)
Why Chinese Firms Are Pouring Money Into US R&D (6/23/2015)
SAIC's New IPR Regulation To Take Effect in August 2015 (6/18/2015)
China's Pharmaceutical Future - Both Complex and Growing (6/18/2015)
China's Healthcare Revolution Goes Digital (6/3/2015)
China's New Healthcare Reform 2020 - Ten Things to Know (5/26/2015)
FT: China Drug Price Reforms Risk Placing Hospitals on Life Support (5/26/2015)
China Pushes Ahead With Plans to Woo International Investors (5/26/2015)
Bloomberg: Foreign Drugmakers Face Pressure to Lower Prices in China (5/25/2015)
Building Better Clinical Trials In China (5/22/2015)
NDRC Abandons Government Pricing Setting, By No Means Letting Go of Control (5/22/2015)
Shanghai Pharma, Wanda Information Tie U...  (7/7/2015)
SMEI Releases Leading Listed Pharma Comp...  (7/6/2015)
Wuzhou Pharma Pays $52M for 10% Stake of...  (7/6/2015)
Hisun Pharma To Tie Up with Sanofi for D...  (7/6/2015)
Upcoming Event: Finance for Non-Finance ...  (7/3/2015) (free)
Upcoming Event: Training Evaluation and ...  (7/3/2015) (free)
Recent Executive Moves  (7/2/2015)
Financial-related Company News in Brief  (7/2/2015)
Provectus Sign LOI with Boehringer for M...  (7/2/2015)
Most Listed Pharma Companies Expected Ne...  (7/2/2015)
GSK's ViiV Healthcare, Dasano Enter Cont...  (7/2/2015)
CFDA Issues New Edition of GSP  (7/2/2015)
Health Survey Finds Rising Chronic Disea...  (6/30/2015)
CFDA Terminates Production and Sales of ...  (6/30/2015)
Review of China Performance of Global To...  (6/30/2015)
Teva Offers to Buy Mylan for $40.1 Billion
Global Strategic Partners Merck and Pfizer Finalize Agre...
Sun Pharma-Ranbaxy Merger Completed Finally
Actavis Closes Allergan Acquisition
Pfizer to Buy Hospira for US$15 Billion
IMS: Review and Outlook of Chinese Hospital Drug Market
IMS: Review and Outlook of Chinese OTC and Retail Pharmacy Mark...
Data Snapshot: Review and Outlook of Chinese Pharma B2C Market
Independent Clinical Lab Industry in China: Market Size and Rap...
New Report: Investigation Report on China's Rituximab Market, 2...
Shanghai Pharma, Wanda Information Tie Up for e-Commerce Opp...
SMEI Releases Leading Listed Pharma Companies by Competitive...
Wuzhou Pharma Pays $52M for 10% Stake of Oramed and China Ri...
Hisun Pharma To Tie Up with Sanofi for Diabetes Drug Develop...
Recent Executive Moves
CFDA Issues New Edition of GSP
CFDA Terminates Production and Sales of Ketoconazole Ora...
China to Target Pharma Enterprises for Fraudulent Invoic...
CFDA Officially Joins the Interim Management Committee o...
CFDA Issues Guidance Policy for Decentralizing Approvals...
China Rejects Patent for Gilead's Expensive Hepatitis C Drug...
Bayer Loses Avelox/Moxifloxacin Patent Battle in China
NDRC to Draft IP Antimonopoly Guideline with Pharma Being A ...
China Passes Amendment to Advertising Law with Stringent Req...
SAIC Investigates Simens and Two Other Medical Device MNCs O...
GSK's ViiV Healthcare, Dasano Enter Contract Manufacture...
EMA Bans Import of Serveral Sterile APIs from Zhuhai Uni...
ScinoPharm, Raffles PharmaTech Cooperates to Produce Cel...
Chinese API Producers Face Tough New Environmental Prote...
USFDA Warns Chinese API Manufacturer Over Manufacturing ...
TCM Anticancer Kanglaite Cleared by the USFDA for Phase ...
BeiGene Gets FDA Nod for IND of BTK Inhibitor BGB-3111
Ascletis Files Clinical Applications for Interferon-Free...
CFDA Ceepts IND of Sucampo's Constipation Drug
CASI Files Phase II Application with CFDA for FLC Antica...
Health Survey Finds Rising Chronic Diseases in China
China and U.S. Group Form Partnerhsip for CVD and CPR Tr...
Review of Off-label Drug Usage in Chinese Hospitals
China Issues National Mental Health Work Plan
NHFPC Issues New Implementation Document for Centralized...
Executive Moves
China Deports Foreign Investigators Linked to GSK Case
China Frees Wife of GSK-linked British Investigator
China Granted Early Release of GSK-linked British Investig...
Senior CFDA Official Investigated for "Disciplinary Violat...
Upcoming Event: Finance for Non-Finance Professionals by...
Upcoming Event: Training Evaluation and ROI Masterclass ...
Upcoming Event: Finance for Non-Finance Professionals by...
Upcoming Event: Training Evaluation and ROI Masterclass ...
Upcoming Event: Finance for Non-Finance Professionals by...
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
  WiCON Publishes China Pharmace...
  WiCON officially publishes Chi...
  Pharma China adds one more dis...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links